PAGEIND.BO
Page Industries Limited
BSEINREQUITY
Consumer Cyclical
DELAYED
Last price
35,490.00
▼ 67.20 (0.19%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
35,201.60
Prev close
35,557.20
Day high
35,898.40
Day low
35,201.60
Volume
429
Market cap
$395.85B
P/E (TTM)
52.36
52W range
29,800.00 – 47,299.95
Day trading desk
Gap from prior close
-1.00%
Prior close 35,557.20
VWAP
35,497.24
-0.02% from price
Relative volume
0.17×
Quiet session
Session range
1.81%
35,201.60 – 35,838.00
Position in range
45%
Mid range
ATR (14D)
897.63
2.53% of price
Prior day high
35,848.35
PDH
Prior day low
35,200.00
PDL
Bid / ask spread
—
Quote not published
Session volume
422
Avg 2.42K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-3.74%
-2.4%
1M
-11.92%
-15.7%
3M
-7.40%
-10.5%
6M
+6.03%
-5.0%
YTD
-1.57%
-13.9%
1Y
-18.45%
-38.4%
3Y
-4.72%
-78.9%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on PAGEIND.BO open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
5.18M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jul 8, 26 | ICICI Prudential MIP 25 Fund Institution- Corporation |
— | 32.53K | — | Direct |
| Dec 3, 25 | ICICI Prudential MIP 25 Fund Institution- Corporation |
— | 15.85K | — | Direct |
| Dec 6, 24 | Nalanda India Fund, Ltd. Institution- Corporation |
— | 29.00K | — | Direct |
| Dec 2, 24 | Genomal (Sunder) Promoter |
SELL | 1.46K | $779.41K | Direct |
| Dec 2, 24 | Hirdaramani (Sadhna Vijay) Promoter |
SELL | 342 | $182.43K | Direct |
| Dec 2, 24 | Mahtani (Simran Keshav) Promoter |
SELL | 338 | $180.31K | Direct |
| Dec 2, 24 | Genomal (Dharmesh Naraindas) Promoter |
SELL | 247 | $131.75K | Direct |
| Dec 2, 24 | Genomal (Ramesh) Promoter |
SELL | 1.47K | $781.51K | Direct |
| Dec 2, 24 | Genomal (Sanjeev Naaraindas) Promoter |
SELL | 500 | $266.76K | Direct |
| Nov 29, 24 | Genomal (Ramesh) Promoter |
SELL | 9.23K | $4.90M | Direct |
| Nov 29, 24 | Genomal (Sanjeev Naaraindas) Promoter |
SELL | 3.20K | $1.70M | Direct |
| Nov 29, 24 | Genomal (Dharmesh Naraindas) Promoter |
SELL | 1.63K | $863.94K | Direct |
| Nov 29, 24 | Genomal (Sunder) Promoter |
SELL | 9.24K | $4.90M | Direct |
| Nov 29, 24 | Hirdaramani (Sadhna Vijay) Promoter |
SELL | 2.26K | $1.20M | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Genomal (Dharmesh Naraindas) |
Promoter | 286.97K | Sale |
Genomal (Ramesh) |
Promoter | 1.59M | Sale |
Genomal (Sanjeev Naaraindas) |
Promoter | 542.25K | Sale |
Genomal (Sunder) |
Promoter | 1.25M | Sale |
Hirdaramani (Sadhna Vijay) |
Promoter | 382.63K | Sale |
ICICI Prudential MIP 25 Fund |
Institution- Corporation | 533.19K | Sale |
Mahtani (Simran Keshav) |
Promoter | 382.63K | Sale |
Nalanda India Fund, Ltd. |
Institution- Corporation | 660.02K | Sale |
Fundamentals
Market cap$395.85B
Enterprise value$394.36B
Revenue (TTM)$53.51B
Gross profit$31.02B
EBITDA$11.03B
Net income$7.56B
EPS (TTM)$677.86
Free cash flow—
Total cash$4.26B
Total debt$2.77B
Book value / share$1,347.15
Shares outstanding11.15M
Float6.37M
Short % of float—
Dividend yield2.25%
Beta (5Y)0.05
Valuation & profitability ratios
Trailing P/E52.36
Forward P/E40.83
PEG ratio1.26
Price / sales—
Price / book26.34
EV / revenue7.37
EV / EBITDA35.75
Gross margin57.98%
Operating margin18.33%
Profit margin14.13%
Return on equity—
Return on assets—
Debt / equity18.42
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $52.27B | $49.13B | $45.47B | $46.78B | +6.4% |
| Operating revenue | $52.27B | $49.13B | $45.47B | $46.78B | +6.4% |
| Cost of revenue | $24.31B | $23.84B | $23.22B | $23.30B | +1.9% |
| Gross profit | $27.97B | $25.29B | $22.25B | $23.49B | +10.6% |
| Selling, general & admin | $4.28B | $4.14B | $3.64B | $2.98B | +3.4% |
| Total operating expense | $17.33B | $15.58B | $14.52B | $15.61B | +11.2% |
| Operating income | $10.64B | $9.71B | $7.73B | $7.88B | +9.6% |
| Net interest income | -$285.25M | -$141.42M | -$235.58M | -$368.30M | -101.7% |
| Pre-tax income | $10.25B | $9.79B | $7.57B | $7.58B | +4.8% |
| Tax provision | $2.62B | $2.49B | $1.87B | $1.87B | +4.8% |
| Net income | $7.64B | $7.29B | $5.69B | $5.71B | +4.8% |
| Net income to common | $7.64B | $7.29B | $5.69B | $5.71B | +4.8% |
| Basic EPS | 684.81 | 653.71 | 510.31 | 512.15 | +4.8% |
| Diluted EPS | 684.81 | 653.71 | 510.31 | 512.15 | +4.8% |
| EBIT | $10.75B | $10.25B | $8.01B | $7.99B | +4.9% |
| EBITDA | $11.82B | $11.24B | $8.92B | $8.77B | +5.1% |
| Basic shares | 11.15M | 11.15M | 11.15M | 11.15M | 0.0% |
| Diluted shares | 11.15M | 11.15M | 11.15M | 11.15M | 0.0% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $2.67B | $2.38B | $331.86M | $6.60M | +12.2% |
| Cash & short-term investments | $4.26B | $4.62B | $3.16B | $6.66M | -7.7% |
| Accounts receivable | $2.01B | $1.92B | $1.59B | $1.46B | +4.9% |
| Inventory | $10.56B | $8.59B | $11.70B | $15.95B | +22.9% |
| Total current assets | $19.11B | $17.42B | $18.76B | $19.62B | +9.7% |
| Property, plant & equipment | $8.81B | $8.43B | $7.33B | $6.66B | +4.4% |
| Goodwill & intangibles | $32.34M | $42.86M | $41.40M | $25.87M | -24.5% |
| Total assets | $28.56B | $26.43B | $26.83B | $26.93B | +8.1% |
| Total current liabilities | $11.08B | $10.10B | $9.38B | $11.94B | +9.6% |
| Current debt | $28.52M | $0 | $0 | $2.48B | — |
| Long-term debt | $90.25M | $0 | — | — | — |
| Total debt | $2.77B | $2.62B | $1.85B | $4.06B | +5.7% |
| Total liabilities | $13.54B | $12.36B | $10.86B | $13.22B | +9.5% |
| Retained earnings | $13.76B | $12.81B | $14.71B | $12.45B | +7.4% |
| Shareholder equity | $15.03B | $14.07B | $15.97B | $13.71B | +6.8% |
| Working capital | $8.03B | $7.32B | $9.37B | $7.68B | +9.7% |
| Net tangible assets | $14.99B | $14.03B | $15.93B | $13.68B | +6.9% |
| Shares issued | 11.15M | 11.15M | 11.15M | 11.15M | 0.0% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | $10.25B | $9.79B | $7.57B | $7.58B | +4.8% |
| Depreciation & amortisation | $1.07B | $992.27M | $903.71M | $780.88M | +7.5% |
| Change in working capital | -$867.56M | $3.64B | $3.80B | -$6.78B | -123.8% |
| Operating cash flow | $7.94B | $12.04B | $10.80B | -$16.08M | -34.0% |
| Capital expenditure | -$1.08B | -$795.66M | -$960.90M | -$1.66B | -35.6% |
| Investing cash flow | -$212.13M | $116.56M | -$3.70B | $307.75M | -282.0% |
| Dividends paid | -$6.69B | -$9.15B | -$3.46B | -$2.90B | +26.8% |
| Financing cash flow | -$7.44B | -$10.10B | -$6.21B | -$1.74B | +26.3% |
| Free cash flow | $6.87B | $11.24B | $9.84B | -$1.67B | -38.9% |
| End cash position | $2.67B | $2.38B | $331.86M | -$559.49M | +12.2% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $12.53B | $13.87B | $12.91B | $13.17B | $10.98B | -9.7% |
| Operating revenue | $12.53B | $13.87B | $12.91B | $13.17B | $10.98B | -9.7% |
| Cost of revenue | $5.21B | $5.83B | $5.17B | $5.38B | $4.29B | -10.7% |
| Gross profit | $7.32B | $8.03B | $7.74B | $7.78B | $6.69B | -8.9% |
| Total operating expense | $4.99B | $5.12B | $5.20B | $5.10B | $4.58B | -2.4% |
| Operating income | $2.33B | $2.92B | $2.54B | $2.68B | $2.10B | -20.3% |
| Net interest income | -$118.81M | -$127.33M | -$125.11M | -$126.60M | -$118.31M | +6.7% |
| Pre-tax income | $2.38B | $2.56B | $2.61B | $2.70B | $2.19B | -7.2% |
| Tax provision | $590.71M | $667.17M | $663.08M | $694.18M | $546.73M | -11.5% |
| Net income | $1.79B | $1.90B | $1.95B | $2.01B | $1.64B | -5.7% |
| Net income to common | $1.79B | $1.90B | $1.95B | $2.01B | $1.64B | -5.7% |
| Basic EPS | 160.24 | 169.93 | 174.62 | 180.02 | 147.04 | -5.7% |
| Diluted EPS | 160.24 | 169.93 | 174.62 | 180.02 | 147.04 | -5.7% |
| EBIT | $2.50B | $2.69B | $2.74B | $2.83B | $2.31B | -7.2% |
| EBITDA | $2.78B | $2.96B | $2.99B | $3.09B | $2.55B | -6.0% |
| Basic shares | 11.15M | 11.15M | 11.15M | 11.15M | 11.15M | +0.0% |
| Diluted shares | 11.15M | 11.15M | 11.15M | 11.15M | 11.15M | +0.0% |
| Line item | 2026-03-31 | 2025-09-30 | 2025-03-31 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $2.67B | $1.59B | $2.38B | +68.2% |
| Cash & short-term investments | $4.26B | $5.08B | $4.62B | -16.0% |
| Accounts receivable | $2.01B | $1.87B | $1.92B | +7.4% |
| Inventory | $10.56B | $9.50B | $8.59B | +11.1% |
| Total current assets | $19.11B | $18.56B | $17.42B | +2.9% |
| Property, plant & equipment | $8.81B | $8.57B | $8.43B | +2.8% |
| Goodwill & intangibles | $32.34M | $35.89M | $42.86M | -9.9% |
| Total assets | $28.56B | $27.86B | $26.43B | +2.5% |
| Total current liabilities | $11.08B | $11.45B | $10.10B | -3.2% |
| Current debt | $28.52M | $16.96M | $0 | +68.1% |
| Long-term debt | $90.25M | $62.08M | $0 | +45.4% |
| Total debt | $2.77B | $2.68B | $2.62B | +3.2% |
| Total liabilities | $13.54B | $13.77B | $12.36B | -1.7% |
| Retained earnings | $13.76B | — | $12.81B | — |
| Shareholder equity | $15.03B | $14.09B | $14.07B | +6.6% |
| Working capital | $8.03B | $7.12B | $7.32B | +12.8% |
| Net tangible assets | $14.99B | $14.05B | $14.03B | +6.7% |
| Shares issued | 11.15M | 11.15M | 11.15M | 0.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 198.05 | 172.86 | -12.7% |
| Mar 2026 | 146.45 | 160.24 | +9.4% |
| Dec 2025 | 185.86 | 192.01 | +3.3% |
| Sep 2025 | 186.33 | 174.62 | -6.3% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 177.34 | 3 | $14.70B | +13.9% |
| Next quarter | 201.73 | 3 | $15.77B | +13.7% |
| Current year | 754.87 | 22 | $59.48B | +13.4% |
| Next year | 869.12 | 23 | $66.15B | +11.2% |
Analyst targets & ownership
Mean target$41,726.65
High target$47,700.00
Low target$31,500.00
Implied upside17.57%
Analyst count26
ConsensusBUY
Strong buy / Buy8 / 8
Hold5
Sell / Strong sell3 / 2
Held by insiders46.43%
Held by institutions43.92%
Institutions holding161
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
36,938.09
-3.92% from price
SMA 20
38,551.13
-7.94% from price
SMA 50
39,794.57
-10.82% from price
SMA 100
38,496.95
-7.81% from price
SMA 200
36,785.35
-3.52% from price
EMA 12
37,133.99
-4.43% from price
EMA 26
38,320.21
-7.39% from price
EMA 50
38,769.52
-8.46% from price
RSI (14)
27.6
Oversold
MACD (12,26,9)
-1,186.22
Hist -390.18
ATR (14)
897.63
2.53% of price
Realised vol 30D
22.6%
Annualised
Bollinger upper
42,218.82
20, 2σ
Bollinger lower
34,883.44
20, 2σ
50 / 200 cross
Golden
39,794.57 vs 36,785.35
Trend bias
Below 200
-3.52%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.26
Less volatile than market
Correlation to SPY
0.14
Largely independent
Realised vol 30D
22.6%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-35.6%
Peak to trough
Max drawdown 5Y
-43.8%
Peak to trough
ATR 14
897.63
2.53% of price
Beta (reported)
0.05
5Y monthly, from filing
Dividends & splits
Forward rate$800.00 / yr
Forward yield2.25%
5-year avg yield1.15%
Payout ratio81.16%
Ex-dividend dateAug 19, 2026
Next pay date—
Last split—
Split date—
Headlines
FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors?
Motley Fool · 5m ago
Vistra Is the Quietest Big Winner of the AI Power Boom. Here's Why.
Motley Fool · 6m ago
AstraZeneca Made a $1.5 Billion Lung Cancer Bet, but Can Zegfrovy Strengthen its Oncology Growth?
Insider Monkey · 6m ago
Uber faces fine of nearly $1B over automated driver suspensions
TechCrunch · 15m ago
This Company Has Raised Its Dividend for 72 Straight Years. Almost Nobody Talks About It.
Motley Fool · 17m ago
This Chinese Tech Giant Quietly Cut Its Buyback 80% to Fund AI
24/7 Wall St. · 28m ago
Look Back: Long before Party on the Patio, Mötley Crüe rocked Pocono Downs
The Times-Leader (Wilkes-Barre, Pa.) · 28m ago
Prediction: ExxonMobil Raises Its Dividend More Than Wall Street Expects
Motley Fool · 29m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.